Stephen Gordon - 01 Feb 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon
Issuer symbol
TMDX
Transactions as of
01 Feb 2024
Net transactions value
-$1,008,599
Form type
4
Filing time
02 Feb 2024, 18:56:07 UTC
Previous filing
03 Jan 2024
Next filing
27 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $117,302 +8,833 +68% $13.28 21,908 01 Feb 2024 Direct F1
transaction TMDX Common Stock Options Exercise $58,814 +3,644 +17% $16.14 25,552 01 Feb 2024 Direct F1
transaction TMDX Common Stock Options Exercise $97,035 +2,523 +9.9% $38.46 28,075 01 Feb 2024 Direct F1
transaction TMDX Common Stock Sale $1,281,750 -15,000 -53% $85.45 13,075 01 Feb 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -8,833 -24% $0.000000 28,167 01 Feb 2024 Common Stock 8,833 $13.28 Direct F1, F3
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3,644 -64% $0.000000 2,084 01 Feb 2024 Common Stock 3,644 $16.14 Direct F1, F4
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -2,523 -3.6% $0.000000 67,477 01 Feb 2024 Common Stock 2,523 $38.46 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
F2 Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
F4 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.
F5 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.